This webinar focuses on the high-impact decisions that determine whether an RNA program advances or stalls during tech transfer. We will explore how template design and process optimization influence purity, reproducibility, and overall development performance. A key focus will be the role of cell-free enzymatic DNA platforms in bypassing the limitations of traditional microbial upstream processes to reduce host cell components while significantly compressing development timelines.